ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
6.05
6.22
Range Annuel
1.98
6.52
Changement quotidien
+7.85%
Changement Mensuel
+59.28%
Evolution sur 6 mois
+71.19%
Changement Annuel
+202.94%
Clôture Précédente
5.7 3
Open
6.0 6
Low
6.0 5
High
6.2 2
Volume
1 579
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Nouvelles